MiraLAX
NDC 11523-4357, Polyethylene Glycol 3350, powder, for solution, from Bayer HealthCare LLC..
- Product NDC
- 11523-4357
- Status
- Listed
- Labeler
- Bayer HealthCare LLC.
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA022015
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11523-4357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYETHYLENE GLYCOL 335017 g/17g
Pharmacologic classes
Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11523-4357-2 | 11523435702 | 2 CARTON in 1 CARTON (11523-4357-2) / 20 PACKET in 1 CARTON / 17 g in 1 PACKET |
| 11523-4357-3 | 11523435703 | 2 BOTTLE, PLASTIC in 1 PACKAGE, COMBINATION (11523-4357-3) / 578 g in 1 BOTTLE, PLASTIC |
| 11523-4357-5 | 11523435705 | 24 PACKET in 1 CARTON (11523-4357-5) / 17 g in 1 PACKET |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11523-4357 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11523-4357 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11523-4357. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.